Pay in 4 interest-free payments of $5.50 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
SA: Investigation, Writing review and editing, Writing original draft
If you are thinking of starting a GLP-1 medication speak to a professional first
The product has been approved by the Central Drugs Standard Control Organization (CDSCO) following a multicentre, randomised, comparative, active-controlled, open-label Phase III clinical study conducted in India, demonstrating favourable efficacy and safety outcomes in Indian patients with Type 2 diabetes
Kowalczyk, M
US$ 26.65
US$ 28.15
US$ 21.51
US$ 24.61
US$ 29.42
